| Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition CR Gil Del Alcazar, SJ Huh, MB Ekram, A Trinh, LL Liu, F Beca, X Zi, ... Cancer discovery 7 (10), 1098-1115, 2017 | 237* | 2017 |
| Re-definition of claudin-low as a breast cancer phenotype C Fougner, H Bergholtz, JH Norum, T Sørlie Nature communications 11 (1), 1787, 2020 | 162 | 2020 |
| Best Practices for Spatial Profiling for Breast Cancer Research with the GeoMx® Digital Spatial Profiler H Bergholtz, JM Carter, A Cesano, MCU Cheang, SE Church, P Divakar, ... Cancers 13 (17), 4456, 2021 | 70 | 2021 |
| Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions H Bergholtz, TG Lien, DM Swanson, A Frigessi, MG Daidone, J Tost, ... NPJ breast cancer 6 (1), 26, 2020 | 32 | 2020 |
| Claudin-low-like mouse mammary tumors show distinct transcriptomic patterns uncoupled from genomic drivers C Fougner, H Bergholtz, R Kuiper, JH Norum, T Sørlie Breast Cancer Research 21, 1-13, 2019 | 23 | 2019 |
| Loss of epigenetic regulation disrupts lineage integrity, induces aberrant alveogenesis, and promotes breast cancer E Langille, KN Al-Zahrani, Z Ma, M Liang, L Uuskula-Reimand, R Espin, ... Cancer discovery 12 (12), 2930-2953, 2022 | 22 | 2022 |
| A Bayesian two-way latent structure model for genomic data integration reveals few pan-genomic cluster subtypes in a breast cancer cohort DM Swanson, T Lien, H Bergholtz, T Sørlie, A Frigessi Bioinformatics 35 (23), 4886-4897, 2019 | 15 | 2019 |
| Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors H Bergholtz, T Lien, F Lingaas, T Sørlie Journal of mammary gland biology and neoplasia 27 (2), 171-183, 2022 | 14 | 2022 |
| Multi-omics marker analysis enables early prediction of breast tumor progression H Xu, T Lien, H Bergholtz, T Fleischer, L Djerroudi, A Vincent-Salomon, ... Frontiers in genetics 12, 670749, 2021 | 14 | 2021 |
| Comparable cancer‐relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer H Bergholtz, S Kumar, F Wärnberg, T Lüders, V Kristensen, T Sørlie Cancer Reports 3 (3), e1248, 2020 | 13 | 2020 |
| GLI1‐induced mammary gland tumours are transplantable and maintain major molecular features JH Norum, O Frings, M Kasper, H Bergholtz, H Zell Thime, Å Bergström, ... International journal of cancer 146 (4), 1125-1138, 2020 | 6 | 2020 |
| A longitudinal study of the association between mammographic density and gene expression in normal breast tissue H Bergholtz, TG Lien, G Ursin, MM Holmen, Å Helland, T Sørlie, ... Journal of mammary gland biology and neoplasia 24, 163-175, 2019 | 6 | 2019 |
| Tailored graphical lasso for data integration in gene network reconstruction C Lingjærde, TG Lien, Ø Borgan, H Bergholtz, IK Glad BMC bioinformatics 22, 1-22, 2021 | 3 | 2021 |
| The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma N Moragas, P Fernandez-Nogueira, L Recalde-Percaz, JL Inman, ... Breast Cancer Research 26 (1), 122, 2024 | | 2024 |
| Abstract PO2-27-04: Unravelling the role of FGFR1 in innate immune sensing and endocrine resistance in breast cancer S Dhakal, TA Lien, JH Norum, H Bergholtz, HM Flatekvål, T Sørlie Cancer Research 84 (9_Supplement), PO2-27-04-PO2-27-04, 2024 | | 2024 |
| Abstract PR05: Spatial transcriptomics of ductal carcinoma in situ reveal subtype specific differences in tumoral and stromal cell compartments H Bergholtz, JH Norum, TG Lien, H Schandiz, T Sauer, J Geisler, T Sørlie Cancer Research 84 (3_Supplement_1), PR05-PR05, 2024 | | 2024 |
| Breast tumors escape endocrine therapy by ER-independent mechanisms triggered by the coordinated activities of HER2/HER3 and deacetylated FOXA1 S Gilfillan, S Wang, MR Katika, JH Norum, H Bergholtz, E Fiorito, ... bioRxiv, 2020.09. 22.308569, 2020 | | 2020 |
| Flukten fra immunsystemet H Bergholtz | | |
Therese SørlieDep. of Cancer Genetics, Inst. for Cancer Research, Oslo University Hospital在 rr-research.no 的电子邮件经过验证
